Prelude Therapeutics Inc (PRLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -99,498 | -127,173 | -121,832 | -115,438 | -111,694 |
| Depreciation Amortization | 1,340 | -2,867 | -2,304 | 3,915 | 2,279 |
| Accounts payable and accrued liabilities | -3,918 | 3,305 | -2,270 | -347 | 3,903 |
| Other Working Capital | 28,409 | 4,216 | -10,479 | 932 | 3,625 |
| Other Operating Activity | 17,365 | 19,631 | 29,822 | 27,209 | 18,356 |
| Operating Cash Flow | $-56,302 | $-102,888 | $-107,063 | $-83,729 | $-83,531 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 53,526 | 90,955 | -31,133 | 84,710 | -261,480 |
| PPE Investments | -67 | -764 | -3,513 | -3,019 | -2,323 |
| Investing Cash Flow | $53,459 | $90,191 | $-34,646 | $81,691 | $-263,803 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -208 | -395 | N/A | N/A | N/A |
| Common Stock Issued | 25,041 | 439 | 136,412 | 815 | 165,200 |
| Other Financing Activity | -17 | -164 | -17 | 0 | -303 |
| Financing Cash Flow | $24,816 | $-120 | $136,395 | $815 | $164,897 |
| Beginning Cash Position | 16,518 | 29,335 | 34,649 | 35,872 | 218,309 |
| End Cash Position | 38,491 | 16,518 | 29,335 | 34,649 | 35,872 |
| Net Cash Flow | $21,973 | $-12,817 | $-5,314 | $-1,223 | $-182,437 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,302 | -102,888 | -107,063 | -83,729 | -83,531 |
| Capital Expenditure | -67 | -764 | -3,513 | -3,019 | -2,323 |
| Free Cash Flow | -56,369 | -103,652 | -110,576 | -86,748 | -85,854 |